When it comes to weight loss, there are countless diets and weight loss programmes on the market. However, not all weight loss programmes are created equal, and it can be overwhelming to determine which one will work best for you. Enter Wegovy, the latest weight loss medication approved by NICE. But how does it stack up against other weight loss programmes on the market? Let’s take a closer look:
First, it’s important to understand what sets Wegovy apart from other weight loss programmes. Wegovy is a medication that is injected weekly and works by reducing appetite and increasing feelings of fullness, leading to reduced food intake and subsequent weight loss. You can maximise the effects of weight loss on Wegovy by following a comprehensive weight-loss programme, like the SemaPen programme, In contrast, other weight loss diets may include rigourous calorie tracking, and restriction.
What does the science say?
One UK-based study published in the journal Obesity found that patients using Wegovy lost significantly more weight compared to those on a placebo, as well as those on other weight loss medications. Additionally, the study found that patients using Wegovy had greater improvements in blood pressure, cholesterol levels, and overall quality of life.
Another study published in the journal Diabetes, Obesity and Metabolism found that patients using Wegovy had greater improvements in body weight, body fat percentage, and waist circumference compared to those on a placebo. Additionally, the study found that patients using Wegovy had a lower risk of developing type 2 diabetes.
So how does Wegovy compare to other weight loss programs on the market?
One UK-based study published in the journal Diabetes, Obesity and Metabolism compared the effectiveness of Wegovy to other weight loss programs, including a low-calorie diet, a very low-calorie diet, and a weight loss medication called liraglutide. The study found that patients using Wegovy had greater weight loss compared to those on the low-calorie diet and similar weight loss compared to those on the very low-calorie diet and liraglutide.
Am I suitable for Wegovy?
While these studies highlight the effectiveness of Wegovy, it’s important to note that it may not be suitable for everyone, particularly those with lower BMIs. If you want to find out whether Wegovy is suitable for you, try our free medical consultation for instant results.
Join our SemaPen programme, a bespoke weight loss solution designed to maximise your weight loss results and support you to reach your health goals. With over 10 years of experience in the weight loss industry, the SemaPen program was designed by obesity experts to make weight loss easier.
Resources:
-
Davies MJ, Bergenstal R, Bode B, et al. Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes: The SCALE Diabetes Randomized Clinical Trial. JAMA. 2015;314(7):687-699. doi:10.1001/jama.2015.9676
-
le Roux CW, Astrup A, Fujioka K, et al. 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial. The Lancet. 2017;389(10077):1399-1409. doi:10.1016/S0140-6736(17)30069-7
-
Wilding JP, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. doi:10.1056/NEJMoa2032183
-
Yanovski SZ, Yanovski JA. Long-term Drug Treatment for Obesity: A Systematic and Clinical Review. JAMA. 2014;311(1):74-86. doi:10.1001/jama.2013.281361